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Letter by Horowitz Regarding Article, “Protein Interactions at Endothelial
Junctions and Signaling Mechanisms Regulating Endothelial Permeability”
To the Editor:
The recent review by Komarova et al1 on Protein Interactions at Endothelial Junctions and
Signaling Mechanisms Regulating Endothelial Permeability addresses a central topic in vascular
biology that plays an important role in diabetes mellitus, cancer, and other common disorders.
However, several statements in the review overlook evidence that does not support the views
they promote:
1.Adherens junctions are presented as the “gatekeeper of the endothelial barrier,” practically the
only junction that is acutely responsive to external stimuli by undergoing turnover. This
statement promotes a common but erroneous assumption in the field. Ultrastructural studies had
shown that tight junctions are pervasive not only in the brain and retina but also in the aorta and
mesenteric artery (reference 40 in the review by Simionescu et al 2) and in the capillaries of the
myocardium3,4 and the lung,5,6 to name a few. Similarly, there is ample evidence for tight
junction turnover in response to agonists, including vascular endothelial growth factor
(VEGF).7,8
2. The review assigns solely a junction-disassembly function to RhoA. Although this is a widelyheld perception, it is simplistic—RhoA participates in both the maintenance and disassembly of
cell junctions. At least in part, this depends on the RhoA effector: activation of Dia promotes
junction stabilization, whereas activation of Rho-associated kinase triggers junction
disassembly.9 This lapse applies also to the spatial control of Rho GTPase activity, where it is
stated that RhoA is suppressed at endothelial adherens junctions. We had shown this is not
always the case.4
3. Figure 2 presents the premise that nonmuscle myosin II unfolds (undergoes 10S–6S transition)
on activation. This premise had been the subject of a long-lasting debate in the smooth muscle
field but was shown conclusively to be incorrect.10 Nonmuscle myosin is highly homologous to
smooth muscle myosin. As far as I know, the folded myosin conformation has never been
detected in either nonmuscle or smooth muscle cells, although a monoclonal antibody specific to
this conformation has been available.11
4. The review states that angiopoietin-1 inhibits VEGFR2 by uncoupling Src from the receptor,
based on an irrelevant reference (reference 179 in the review by Whittard and Akiyama
12
), while overlooking evidence showing that Src inhibition by angiopoietin-1 is mediated
through the sequestration of the kinase away from VEGFR2 by Dia.13
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